Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis

Table 1 Main characteristics of the included studies

Study	Year	Sample size		Age in yr		Sex, male/female		Approach	Neoadjuvant chemotherapy	Follow-up(d)
		ERAS	SC	ERAS	SC	ERAS	SC
Abdikarim et al[21]	2015	30	31	63 ± 12	62 ± 11	21/9	20/11	Lap	No	30
Bu et al[23]-Adult	2015	64	64	62.4 ± 7.8	63.0 ± 7.4	31/33	35/29	Open	No	30
Bu et al[23]-Elderly	2015	64	64	80.1 ± 4.0	79.6 ± 3.5	37/27	40/24	Open	No	30
Chen Hu et al[34]-Lap	2012	19	22	59 (49-71)	62.5 (45-72)	10/9	10/12	Lap	No	28
Chen Hu et al[34]-Open	2012	21	20	62.5 (45-72)	64.5 (49-75)	9/12	12/8	Open	No	28
Feng et al[33]	2013	59	60	55.0 ± 11.4	55.8 ± 10.1	41/18	44/16	Open	No	28
Kim et al[35]	2012	22	22	52.6 ± 11.6	57.5 ± 14.5	13/9	15/7	Lap	-	14
Liu et al[36]	2010	33	30	60.7 ± 9.7	61.9 ± 8.3	18/15	16/14	Open	No	30
Liu et al[24]-Lap	2016	21	21	69.2 ± 5.1	70.3 ± 5.8	10/11	12/9	Lap	No	30
Liu et al[24]-Open	2016	21	21	67.8 ± 3.9	68.6 ± 4.9	9/12	11/10	Open	No	30
Mingjie et al[22]	2017	73	76	61 (40-75)	63 (35-75)	48/25	50/26	Lap	No	30
Tanaka et al[30]	2017	73	69	68 (29-85)	67 (44-85)	49/24	49/20	Lap/Open	No	30
Wang et al[37]	2010	45	47	58.8 ± 9.7	56.9 ± 9.1	32/13	29/18	Open	No	28

ERAS: Enhanced recovery after surgery; Lap: laparoscopic surgery; Open: Open surgery; SC: Standard care.